Retraction
ATPase inhibitory factor 1 is a prognostic marker and contributes to proliferation and invasion of human gastric cancer cells
Paper Information
Record ID:
43149
Author(s):
Journal:
Publication Date:
January 12, 2015
Retraction Date:
January 31, 2023
(2.8 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.biopha.2023.114281Additional Notes:
see also: https://pubpeer.com/publications/C02E9E0E8189253D1EB9BA6C925907
Citations (29)
29
Total Citations1
Post-Retraction(3.4%)
28
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
563
Days since retraction (latest)
Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice
Kimberly Richardson, Gareeballah Osman Adam, Wen Ling et al. (11 authors)
Molecular Metabolism
Open Access
Published: Aug 2024
3 citations
3 citations
563 days after retraction
The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis
Chiara Galber, Simone Fabbian, Cristina Gatto et al. (13 authors)
Cell Death and Disease
Open Access
Published: Jan 2023
20 citations
20 citations
8 days before retraction
The F1Fo-ATPase inhibitor protein IF1 in pathophysiology
Cristina Gatto, Martina Grandi, Giancarlo Solaini et al. (5 authors)
Frontiers in Physiology
Open Access
Published: Aug 2022
15 citations
15 citations
180 days before retraction
The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders?
Emilia Gore, Thibaut Duparc, Annelise Genoux et al. (6 authors)
Antioxidants and Redox Signaling
Open Access
Published: Oct 2021
37 citations
37 citations
484 days before retraction
The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells
Giancarlo Solaini, Gianluca Sgarbi, Alessandra Baracca
Biochemical Society Transactions
Published: Apr 2021
13 citations
13 citations
641 days before retraction
Cancer cell metabolism: Rewiring the mitochondrial hub
Gabriela Lopes Oliveira, Ana R. Coelho, Ricardo Marques et al. (4 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Open Access
Published: Nov 2020
54 citations
54 citations
797 days before retraction
Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth
Cristina Nuevo‐Tapioles, Fulvio Santacatterina, Konstantinos Stamatakis et al. (7 authors)
Nature Communications
Open Access
Published: Jul 2020
94 citations
94 citations
928 days before retraction
ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy
Jian Kong, Changyu Yao, Xuemei Ding et al. (7 authors)
Frontiers in Oncology
Open Access
Published: Jun 2020
27 citations
27 citations
950 days before retraction
Metabolic reprogramming and disease progression in cancer patients
Laura Torresano, Cristina Nuevo‐Tapioles, Fulvio Santacatterina et al. (4 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Open Access
Published: Feb 2020
61 citations
61 citations
1085 days before retraction
Overexpression of Mitochondrial IF1 Prevents Metastatic Disease of Colorectal Cancer by Enhancing Anoikis and Tumor Infiltration of NK Cells
Lucía González-Llorente, Fulvio Santacatterina, Ana García-Aguilar et al. (8 authors)
Cancers
Open Access
Published: Dec 2019
35 citations
35 citations
1139 days before retraction
Oncogenic pathways and the electron transport chain: a dangeROS liaison
Vittoria Raimondi, Francesco Ciccarese, Vincenzo Ciminale
British Journal of Cancer
Open Access
Published: Dec 2019
158 citations
158 citations
1148 days before retraction
Control of rotation of the F1FO-ATP synthase nanomotor by an inhibitory α-helix from unfolded ε or intrinsically disordered ζ and IF1 proteins
Francisco Mendoza-Hoffmann, Mariel Zarco‐Zavala, Raquel Ortega et al. (4 authors)
Journal of Bioenergetics and Biomembranes
Published: Sep 2018
18 citations
18 citations
1586 days before retraction
Faculty Opinions recommendation of F1F0-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation.
Silvana Curci, Matilde Colella
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Open Access
Published: Aug 2018
1624 days before retraction
ATPase inhibitory factor 1 inhibition improves the antitumor of YC‑1 against hepatocellular carcinoma
Xuemei Ding, Jian Kong, Wenlei Xu et al. (10 authors)
Oncology Letters
Open Access
Published: Aug 2018
5 citations
5 citations
1642 days before retraction
F1F0-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation
Helen Tanton, Svetlana Voronina, A.G. Evans et al. (11 authors)
Frontiers in Physiology
Open Access
Published: Jul 2018
9 citations
9 citations
1665 days before retraction
The Role of Mitochondrial H+-ATP Synthase in Cancer
Pau B. Esparza‐Moltó, José M. Cuezva
Frontiers in Oncology
Open Access
Published: Mar 2018
65 citations
65 citations
1792 days before retraction
Regulation of glucose‐stimulated insulin secretion by <scp>ATP</scp>ase Inhibitory Factor 1 (<scp>IF</scp>1)
Anežka Kahancová, Filip Sklenář, Petr Ježek et al. (4 authors)
FEBS Letters
Open Access
Published: Jan 2018
35 citations
35 citations
1827 days before retraction
Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier‐Onset Prostate Cancer
René G. Feichtinger, Georg Schäfer, Christof Seifarth et al. (6 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jan 2018
21 citations
21 citations
1856 days before retraction
ATPase inhibitory factor 1 (IF1): a novel player in pollutant-related diseases?
Kévin Hardonnière, Dominique Lagadic‐Gossmann
Current Opinion in Toxicology
Published: Dec 2017
2 citations
2 citations
1867 days before retraction
Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer
Lucía García‐Ledo, Cristina Nuevo‐Tapioles, Carmen Cuevas-Martín et al. (7 authors)
Frontiers in Oncology
Open Access
Published: Apr 2017
23 citations
23 citations
2122 days before retraction
Role for the ATPase inhibitory factor 1 in the environmental carcinogen-induced Warburg phenotype
Kévin Hardonnière, Morgane Fernier, Isabelle Gallais et al. (14 authors)
Scientific Reports
Open Access
Published: Mar 2017
19 citations
19 citations
2154 days before retraction
Mitochondrial metabolism and energy sensing in tumor progression
Luisa Iommarini, Anna Ghelli, Giuseppe Gasparre et al. (4 authors)
Biochimica et Biophysica Acta (BBA) - Bioenergetics
Open Access
Published: Feb 2017
57 citations
57 citations
2176 days before retraction
Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis
Fulvio Santacatterina, María Sánchez‐Aragó, Marc Catalán‐García et al. (8 authors)
Journal of Translational Medicine
Open Access
Published: Feb 2017
17 citations
17 citations
2181 days before retraction
Regulation of the H+-ATP synthase by IF1: a role in mitohormesis
Pau B. Esparza‐Moltó, Cristina Nuevo‐Tapioles, José M. Cuezva
Cellular and Molecular Life Sciences
Open Access
Published: Feb 2017
54 citations
54 citations
2185 days before retraction
Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1
Danilo Faccenda, Junji Nakamura, Giulia Gorini et al. (7 authors)
Cell Reports
Open Access
Published: Feb 2017
71 citations
71 citations
2190 days before retraction
New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity
Xian Li, Huijun Wu, Xiaohui Ouyang et al. (5 authors)
Oncology Reports
Open Access
Published: Jan 2017
18 citations
18 citations
2221 days before retraction
Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents
Mauro Corrado, Luca Scorrano, Silvia Campello
Oncotarget
Open Access
Published: Apr 2016
27 citations
27 citations
2484 days before retraction
The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival
Javier García‐Bermúdez, José M. Cuezva
Biochimica et Biophysica Acta (BBA) - Bioenergetics
Open Access
Published: Feb 2016
121 citations
121 citations
2545 days before retraction
Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state
Fulvio Santacatterina, Laura Sánchez-Cenizo, Laura Formentini et al. (14 authors)
Oncotarget
Open Access
Published: Nov 2015
64 citations
64 citations
2627 days before retraction
Quick Stats
Total Citations:
29
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025